BTI
KYMR icon

Blue Trust Inc’s Kymera Therapeutics KYMR Stock Holding History

Blue Trust Inc’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-247
Closed -$6.76K – 2545
2025
Q1 		$6.76K Hold
247
– – ﹤0.01% 2044
2024
Q4 		$9.94K Sell
247
-114
-32% -$5.15K ﹤0.01% 1876
2024
Q3 		$10.8K Buy
361
+83
+30% +$3.67K ﹤0.01% 2171
2024
Q2 		$11.2K Buy
+278
New +$9.63K ﹤0.01% 1895
2023
Q3 		– Sell
-20
Closed -$1K – 2179
2023
Q2 		$1K Buy
20
+7
+54% +$201 ﹤0.01% 1875
2023
Q1 		$0 Sell
13
-8
-38% -$258 ﹤0.01% 2485
2022
Q4 		$0 Sell
21
-79
-79% -$2.11K ﹤0.01% 2357
2022
Q3 		$2K Buy
+100
New +$2.64K ﹤0.01% 1798

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return